RADx-UP- Impact of Community Health Worker Deployment
1 other identifier
interventional
87
1 country
1
Brief Summary
The proposed project will implement and evaluate a brief Community Health Worker (CHW) intervention through the Albany Area Primary Health Care, a rural Federally Qualified Health Center (FQHC). The primary goal of this study is to maximize effective outreach, education, and communication through CHWs in order to facilitate improved COVID-19 vaccine confidence and uptake in underserved and vulnerable communities. CHWs will be deployed to the homes of adults with increased risk of morbidity and mortality (i.e., African Americans or Latinos with uncontrolled diabetes or prediabetes, age \<50 years, and non-COVID-19 vaccinated) in order to educate them about diabetes, COVID-19 and related vaccines. Health assessments, including blood glucose measurement, will be conducted on the indexed patient and offered to all other adult family members in the household (i.e., "bubble"). Adults with Type 2 diabetes likely live in households with other adults who have or are at increased risk for diabetes (i.e., prediabetes and obesity).1 It is expected that they will also share similar COVID-19 exposure risk. The specific aims are to: 1) Evaluate a community-driven education program to increase and enhance COVID-19 vaccine confidence and uptake in individuals with uncontrolled diabetes and their families (i.e., their "bubble") and 2) Evaluate a community-driven education program to improve diabetes self-management behaviors and related outcomes (e.g., blood glucose) in individuals with uncontrolled diabetes in rural, Southwest Georgia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable diabetes
Started Feb 2022
Typical duration for not_applicable diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 11, 2022
CompletedFirst Submitted
Initial submission to the registry
December 2, 2022
CompletedFirst Posted
Study publicly available on registry
May 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2025
CompletedJuly 31, 2025
July 1, 2025
2.8 years
December 2, 2022
July 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood Glucose Level
Change in HbA1c level from using clinical assessment parameters from week 1 to week 6.
6 weeks
Secondary Outcomes (1)
Diabetes Self-Management Score
6 weeks
Other Outcomes (1)
COVID-19 Vaccination Confidence and Uptake
6 weeks
Study Arms (1)
CHW Intervention
OTHERA six week CHW home-visit behavioral intervention examining changes in diabetes outcomes.
Interventions
CHWs will conduct home visits to provide diabetes and COVID-19 health education based on the participant's needs, interests, and clinical health assessment results. All adults in the household will be invited to participate in the health education discussions. At each visit, the CHW will use diabetes management and COVID-19 educational materials to facilitate and inform discussions. CHWs will also make available at-home COVID-19 testing kits with instructions for the patient and their household family members. The discussion of COVID-19 beliefs, perceptions, and related behaviors will be raised during a later visit, i.e., after rapport and trust has been established and if it has not been raised by the participants during the earlier visits. In addition, CHWs will help schedule vaccination and healthcare appointments upon participant's interest.
Eligibility Criteria
You may qualify if:
- Participants must be between18 and 50 years
- Self-identify as African American/Black or Latino
- English speaking
- Have received care for uncontrolled diabetes (HbA1c \> 9%) or prediabetes diagnosis within one of the AAPHC 27 community sites
- Unvaccinated for Phase 1 (vaccinated for Phase 2)
You may not qualify if:
- Enrolled in the parent RADx-UP Project PEACH study
- Unable or unwilling to provide informed consent to participate in the study (ie: incarcerated individuals and children)
- Individuals with a terminal cancer diagnosis, have chronic kidney disease (stage 4-5), pregnant women, and people with severe psychological disorders (i.e., dementia,suicide ideation)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Albany Area Primary Health Care
Albany, Georgia, 31707, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rakale C Quarells, PhD
Morehouse School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 2, 2022
First Posted
May 18, 2023
Study Start
February 11, 2022
Primary Completion
November 30, 2024
Study Completion
April 30, 2025
Last Updated
July 31, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share